Your browser doesn't support javascript.
loading
Role of buccal mucosa graft ureteroplasty in the surgical management of pyeloplasty failure.
Lee, Matthew; Nagoda, Elizabeth; Strauss, David; Loecher, Matthew; Stifelman, Michael; Zhao, Lee.
Afiliación
  • Lee M; Department of Urology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
  • Nagoda E; Department of Urology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
  • Strauss D; Department of Urology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
  • Loecher M; Department of Urology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
  • Stifelman M; Department of Urology, Hackensack Meridian School of Medicine, Hackensack University Medical Center, Hackensack, NJ, USA.
  • Zhao L; Department of Urology, New York University Grossman School of Medicine, New York University Langone Health System, New York, NY, USA.
Asian J Urol ; 11(3): 373-376, 2024 Jul.
Article en En | MEDLINE | ID: mdl-39139522
ABSTRACT

Objective:

Secondary pyeloplasty for recurrent ureteropelvic junction obstructions may be a safe and feasible surgical option for patients. This study aimed to demonstrate outcomes of utilizing a non-transecting buccal mucosa graft ureteroplasty for management of recurrent ureteropelvic junction obstruction after prior failed pyeloplasty.

Methods:

We performed a retrospective review of our Collaborative of Reconstructive Robotic Ureteral Surgery database for all consecutive patients who underwent buccal mucosa graft ureteroplasty between April 2012 and June 2022 for management of recurrent ureteropelvic junction obstructions after prior failed pyeloplasty. The primary outcome included surgical success which was defined as the absence of flank pain and no obstruction on imaging.

Results:

Overall, ten patients were included in our analysis. The median stricture length was 2.5 (interquartile range [IQR] 1.8-4.0) cm. The median operative time was 230.5 (IQR 199.5-287.0) min and median estimated blood loss was 50.0 (IQR 28.8-102.5) mL. At a median follow-up of 10.3 (IQR 6.2-14.8) months, 80% of patients were surgically successful and there were no major (Clavien-Dindo Grade>2) complications.

Conclusion:

Buccal mucosa graft ureteroplasty is a valuable non-transecting surgical option for patients with recurrent ureteropelvic junction obstructions who failed prior pyeloplasty and has comparable outcomes to the literature regarding standard transecting techniques.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Asian J Urol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Singapur
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Asian J Urol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Singapur